PTThe Paper Trail Project
PharmaceuticalsPaper Trail research

Amgen Inc.

Amgen Inc. is an organization in the Pharmaceuticals sector. Paper Trail tracks its public-money, lobbying, campaign-finance, corporate, and People relationships where supported by public records.

At a Glance

Highlights from available records. Missing information does not mean an activity did not occur.

Editorial context

Why It Is Included

Included as a major institution relevant to Paper Trail research; individual public-record connections appear only when sourced.

Connection explorer

Follow the Full Trail

Move from this organization to federal agencies, spending categories, reviewed corporate relationships, lobbying disclosures, its affiliated PAC, and political recipients.

Open Connection Explorer →

Corporate structure

What does Amgen Inc. control?

Business segments, subsidiaries, joint ventures, and acquired companies connected to the parent organization.

Legal-subsidiary lists are drawn from reviewed SEC Exhibit 21 filings. Companies may omit subsidiaries that are not considered significant under SEC reporting rules, so these lists are not necessarily exhaustive.

Legal subsidiaries42
Amgen (Europe) GmbH

Switzerland

SEC filing source ↗
Amgen Canada Inc

Canada

SEC filing source ↗
Amgen Fremont Inc

Delaware

SEC filing source ↗
Amgen Global Finance B.V

Netherlands

SEC filing source ↗
Amgen Global Technology Unlimited Company

Ireland

SEC filing source ↗
Amgen GmbH Germany

Germany

SEC filing source ↗
Amgen Ilaç Ticaret Limited Şirketi

Türkiye

SEC filing source ↗
Amgen International Holdings Inc

Delaware

SEC filing source ↗
Amgen K-A, Inc

Delaware

SEC filing source ↗
Amgen K.K

Japan

SEC filing source ↗
Amgen Manufacturing Limited LLC

Puerto Rico

SEC filing source ↗
Amgen Rare Disease Holdings Inc

Delaware

SEC filing source ↗
Amgen Research (Munich) GmbH

Germany

SEC filing source ↗
Amgen S.A.S

France

SEC filing source ↗
Amgen S.p.A

Italy

SEC filing source ↗
Amgen SF, LLC

Delaware

SEC filing source ↗
Amgen Singapore Holding Pte. Ltd

Singapore

SEC filing source ↗
Amgen Singapore Manufacturing Pte. Ltd

Singapore

SEC filing source ↗
Amgen Technology (Ireland) Unlimited Company

Ireland

SEC filing source ↗
Amgen Technology, Limited

Bermuda

SEC filing source ↗
Amgen USA Inc

Delaware

SEC filing source ↗
Amgen Worldwide Holdings B.V

Netherlands

SEC filing source ↗
Amgen, S.A

Spain

SEC filing source ↗
BioVex LLC

Delaware

SEC filing source ↗
ChemoCentryx, Inc

Delaware

SEC filing source ↗
Five Prime Therapeutics, Inc

Delaware

SEC filing source ↗
Horizon Therapeutics Finance S.à.r.l

Luxembourg

SEC filing source ↗
Horizon Therapeutics Holdings Limited

Ireland

SEC filing source ↗
Horizon Therapeutics Ireland DAC

Ireland

SEC filing source ↗
Horizon Therapeutics Limited

Ireland

SEC filing source ↗
Horizon Therapeutics Services LLC

Delaware

SEC filing source ↗
Horizon Therapeutics U.S. Holding LLC

Delaware

SEC filing source ↗
Horizon Therapeutics USA, Inc

Delaware

SEC filing source ↗
HZNP Finance Limited

Bermuda

SEC filing source ↗
Immunex Corporation

Washington

SEC filing source ↗
Immunex Rhode Island Corporation

Delaware

SEC filing source ↗
Onyx Pharmaceuticals, Inc

Delaware

SEC filing source ↗
Onyx Therapeutics, Inc

Delaware

SEC filing source ↗
Pillartree Limited

Ireland

SEC filing source ↗
Saga Investments Coöperatief U.A

Netherlands

SEC filing source ↗
TeneoBio, Inc

Delaware

SEC filing source ↗
Viela Bio, Inc

Delaware

SEC filing source ↗
Acquisitions10
Celgene Corporation. OtezlaSEC filing source ↗
Celgene. OtezlaSEC filing source ↗
equity stake in BeiGeneSEC filing source ↗
equity stake in BeOneSEC filing source ↗
Horizon. For 2022SEC filing source ↗
through our acquisition of Horizon for patents and know-howSEC filing source ↗

Document library

Important Documents

Selected filings, reports, contracts, court records, and other documents useful for understanding this organization.

SEC Exhibit 21Company filing

Amgen Inc. Exhibit 21 — Subsidiaries

Amgen Inc. · Feb 13, 2026

Company-filed list of significant subsidiaries. The filing may omit subsidiaries that are not considered significant under SEC rules.

Documentation

Sources

For researchers

Cite this page

The Paper Trail Project. “Amgen Inc..” Accessed November 7, 2026. https://www.papertrailproject.org/profiles/amgen

Methodology

Record last updated 2026-09-02. Sources: Official organization website. Verify consequential claims against the linked original records.